From: Therapeutic potential of heterocyclic pyrimidine scaffolds
Compounds
(%) Activity PfDHODH
IC50 against PfDHODH (µM)
d7
67.474 ± 0.002
6 ± 1
d8
41 ± 3
4 ± 1
d9
77 ± 1
–
d10
60 ± 3
0.16 ± 0.01